Jane Holmes
Senior Clinical Trials Methodologist
Recent publications
-
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
Journal article
Mukherjee S. et al, (2024), European Journal of Cancer, 209
-
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: the PANORAMIC trial
Journal article
Png ME. et al, (2024), British Journal of General Practice, 74, e570 - e579
-
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method
Journal article
Javed SR. et al, (2024), British Journal of Cancer, 130, 467 - 475
-
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participants
Journal article
Goncalves MB. et al, (2023), British Journal of Clinical Pharmacology, 89, 3573 - 3583
-
Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): Protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Journal article
Gbinigie O. et al, (2023), BMJ Open, 13